113 S1091 IS: To provide for the issuance of an Alzheimer’s Disease Research Semipostal Stamp. U.S. Senate 2013-06-04 text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.

II 113th CONGRESS 1st Session S. 1091 IN THE SENATE OF THE UNITED STATES June 4, 2013 Ms. Mikulski introduced the following bill; which was read twice and referred to the Committee on Homeland Security and Governmental Affairs A BILL To provide for the issuance of an Alzheimer’s Disease Research Semipostal Stamp.

1.

Alzheimer's Disease Research Semipostal Stamp

(a)

In general

In order to afford a convenient way for members of the public to contribute to funding for medical research relating to Alzheimer's disease, the United States Postal Service shall issue a semipostal stamp (referred to in this Act as the Alzheimer's Disease Research Semipostal Stamp) in accordance with the provisions of this section. (b)

Terms and conditions

(1)

In general

The issuance and sale of the Alzheimer's Disease Research Semipostal Stamp shall be governed by the provisions of section 416 of title 39, United States Code, and regulations issued under such section, subject to the requirements of this subsection. (2)

Duration

The Alzheimer's Disease Research Semipostal Stamp shall be made available to the public for a period of 6 years, beginning no later than 12 months after the date of the enactment of this Act. (3)

Disposition of proceeds

All amounts becoming available from the sale of the Alzheimer's Disease Research Semipostal Stamp (as determined under section 416(d) of such title 39) shall be transferred to the National Institutes of Health, for the purpose described in subsection (a), through payments which shall be made at least twice a year. (c)

Definition

For purposes of this Act, the term semipostal stamp refers to a stamp described in section 416(a)(1) of title 39, United States Code.